Advanced Biomedical Technologies Hisse

Advanced Biomedical Technologies EBITDA

Advanced Biomedical Technologies (ABMT) öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 26 Ağu 2026 itibarıyla -429.600,00 USD dir. Önceki yılda, EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) -583.500,00 USD idi — -26,38% (daha yüksek) bir değişiklik.

EBITDA

-429.600,00USD

YoY

-26,38%

Son güncelleme:

Advanced Biomedical Technologies öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 2026 -429.600,00 USD dir. Advanced Biomedical Technologies öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 2025 -583.500,00 USD idi. %-26,38 daha yüksek önceki yıla kıyasla azalmaktadır.

Advanced Biomedical Technologies EBITDA Tarihçesi

  • 3 yıl

  • 10 yıl

  • 25 Yıl

  • Maks.

EBITDA
Date
EBITDA
1 Oca 2015
-574.700,00 USD
1 Oca 2016
-431.700,00 USD
1 Oca 2017
-390.000,00 USD
1 Oca 2018
-617.700,00 USD
1 Oca 2019
-583.500,00 USD
1 Oca 2020
-429.600,00 USD
Advanced Biomedical Technologies EBITDA Tarihçesi
YILEBITDAYoY
-429.600,00USD-26,38%
-583.500,00USD-5,54%
-617.700,00USD+58,38%
-390.000,00USD-9,66%
-431.700,00USD-24,88%
-574.700,00USD
Access this data via the Eulerpool API

Advanced Biomedical Technologies Hisse senedi analizi

Advanced Biomedical Technologies ne yapar? Advanced Biomedical Technologies Inc is an innovative biomedical company specializing in the development of advanced medical devices and technologies. The company was founded in 1985 by an experienced team of biotech experts and is headquartered in California, USA. History: The company's roots lie in the research and development of novel medical implants and prosthetics. However, over the years, the company has quickly evolved into a leading provider of medical devices and technologies in the fields of diagnostics, therapy, and care. Business model: The business model of Advanced Biomedical Technologies Inc is focused on providing innovative and advanced solutions for medical care. The company strives to continuously develop its products and help customers achieve their healthcare goals. Divisions: The company is divided into four main divisions focusing on different medical areas: 1) Interventional Cardiology: Here, the company develops devices for the treatment of heart diseases, such as stents for reopening narrowed vessels. 2) Orthopedics: Another focus is on the development of innovative orthopedic implants and prosthetics that help patients regain their mobility and improve their quality of life. 3) Oncology: In this division, the company works on the development of medical devices and systems for the diagnosis and treatment of cancer. 4) Neurology: Here, the company focuses on the development of medical technologies and devices for the diagnosis and treatment of nervous system disorders, such as Parkinson's or Alzheimer's. Products: Advanced Biomedical Technologies Inc's products include a variety of medical devices and technologies specialized in different medical areas. Some of the company's most well-known products are: - Stents for reopening narrowed vessels in the heart - Artificial joints and implants for restoring mobility and quality of life - Medical devices for the diagnosis and treatment of cancer - Neurostimulation devices for the treatment of chronic pain and other neurological disorders - Robot-assisted surgery systems that assist surgeons in complex procedures. Conclusion: Advanced Biomedical Technologies Inc is a leading biomedical company specializing in the development of advanced medical devices and technologies. The company has a long history in the research and development of medical implants and prosthetics but has quickly expanded into a broader range of medical applications. With its focus on developing innovative products for patients' quality of life, Advanced Biomedical Technologies Inc will continue to play an important role in medical innovation. Advanced Biomedical Technologies, Eulerpool'daki en popüler şirketlerden biridir.

Advanced Biomedical Technologies hisse senedi hakkında sık sorulan sorular

Advanced Biomedical Technologies şirketinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 2026 yılında -429.600,00 USD.

Advanced Biomedical Technologies öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri -583.500,00 USD değerinden -429.600,00 USD değerine değişmiş ve bu %-26,38 değişimi temsil etmektedir. Değer önceki yıldan daha yüksek dir.

Eulerpool'da EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) öğesinin Advanced Biomedical Technologies değerinin 2006'dan itibaren tam tarihsel gelişimini bulabilirsiniz — yıllık değerler, grafikler ve ayrıntılı analiz ile.

EBITDA, finansal yapı, vergi ortamı ve nakit olmayan amortisman giderleri etkisinden önceki işletme performansını ölçer.

EBITDA = EBIT + Amortisman

EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr)'nin USD, yatırımcılar için kilit bir faktördür. Bu metrikte yapılan değişiklikler temel faktörlerin iyileşmesini veya kötüleşmesini gösterebilir ve hisse senedi fiyatını doğrudan etkiler. Eulerpool'da EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr)'nin Advanced Biomedical Technologies değerini tarihsel olarak ve gerçek zamanlı olarak takip edebilirsiniz.

Access this data via the Eulerpool API

Gelir Tablosu — Advanced Biomedical Technologies

Tüm Kilit Metrikler — Advanced Biomedical Technologies